Idexx Laboratories | IDXX - Current Liabilities

Stock Price
565.93
Daily Change
5.00 0.89%
Monthly
-1.70%
Yearly
29.37%
Q2 Forecast
576.29

Idexx Laboratories reported $1.15B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Accuray USD 194.61M 2.03M Sep/2025
Align Technology USD 1.92B 46.45M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Dentsply International USD 1.34B 62M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.81B 225.7M Dec/2025
Fujifilm JPY 1.2T 44.21B Dec/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Henry Schein USD 3.23B 79M Dec/2025
Idexx Laboratories USD 1.15B 103M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Intuitive Surgical USD 2.51B 3.2M Mar/2026
Masimo USD 371.6M 1.9M Dec/2025
Neogen USD 150.6M 3.55M Dec/2025
Orthofix International USD 170.48M 10.64M Dec/2025
Phibro Animal Health USD 282.37M 12.23M Dec/2025
ResMed USD 1.25B 7.39M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Steris USD 922.3M 33.4M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Zoetis USD 2.24B 428M Dec/2025